{"id":83995,"date":"2025-08-15T05:30:06","date_gmt":"2025-08-15T05:30:06","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/83995\/"},"modified":"2025-08-15T05:30:06","modified_gmt":"2025-08-15T05:30:06","slug":"meiragtx-reports-progress-in-genetic-medicines-development","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/83995\/","title":{"rendered":"MeiraGTx Reports Progress in Genetic Medicines Development"},"content":{"rendered":"<p>Meiragtx Holdings ( <a data-ticker=\"MGTX\" href=\"https:\/\/www.tipranks.com\/stocks\/mgtx\" rel=\"nofollow noopener\" target=\"_blank\">(MGTX)<\/a> ) has released its Q2 earnings. Here is a breakdown of the information Meiragtx Holdings presented to its investors.<\/p>\n<p>Elevate Your Investing Strategy: Take advantage of <a data-link=\"article_promo\" href=\"https:\/\/lp.tipranks.com\/july-2025-50off\/?llf=rss&amp;timer=on&amp;coupon=INTRO50P\" rel=\"nofollow noopener\" target=\"_blank\"> TipRanks Premium at 50% off! <\/a> Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.<\/p>\n<p>MeiraGTx Holdings plc is a clinical-stage genetic medicines company focused on developing innovative therapies for inherited and common diseases, with a strong emphasis on end-to-end in-house manufacturing capabilities. In its latest earnings report, MeiraGTx highlighted significant regulatory progress and strategic collaborations, notably gaining FDA alignment for its Phase 2 study in radiation-induced xerostomia and receiving RMAT designation for its Parkinson\u2019s disease treatment. Key financial metrics showed a net loss reduction compared to the previous year, with service revenue increasing due to enhanced collaboration with Johnson &amp; Johnson. The company also announced a strategic partnership with Hologen to advance its Parkinson\u2019s disease program and other CNS therapies, supported by a $200 million investment. Looking ahead, MeiraGTx remains focused on advancing its late-stage clinical programs and leveraging its proprietary technologies to address unmet medical needs, with a robust financial position to support its strategic initiatives into 2027.<\/p>\n<p><a href=\"https:\/\/www.tipranks.com\/glossary\/d\/disclaimer-disclosure\" style=\"margin-right: 32px;\" rel=\"nofollow noopener\" target=\"_blank\">Disclaimer &amp; Disclosure<\/a><a href=\"https:\/\/www.tipranks.com\/glossary\/c\/contact-editor\" rel=\"nofollow noopener\" target=\"_blank\">Report an Issue<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Meiragtx Holdings ( (MGTX) ) has released its Q2 earnings. Here is a breakdown of the information Meiragtx&hellip;\n","protected":false},"author":2,"featured_media":83996,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[50],"tags":[200,79],"class_list":["post-83995","post","type-post","status-publish","format-standard","has-post-thumbnail","category-genetics","tag-genetics","tag-science"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/83995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=83995"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/83995\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/83996"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=83995"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=83995"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=83995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}